BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hueman MT, Vollmer CM, Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16:2101-2115. [PMID: 19495882 DOI: 10.1245/s10434-009-0538-x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 89] [Article Influence: 9.6] [Reference Citation Analysis]
Number Citing Articles
1 Dong Y, Xu B, Cao Q, Zhang Q, Qiu Y, Yang D, Yu L, Wang WP. Incidentally detected focal fundal gallbladder wall thickening: Differentiation contrast enhanced ultrasound features with high-resolution linear transducers. Clin Hemorheol Microcirc. 2020;74:315-325. [PMID: 31524151 DOI: 10.3233/ch-190697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Rungsakulkij N, Boonsakan P. Synchronous gallbladder and pancreatic cancer associated with pancreaticobiliary maljunction. World J Gastroenterol 2014;20:14500-4. [PMID: 25339838 DOI: 10.3748/wjg.v20.i39.14500] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Birnbaum DJ, Viganò L, Ferrero A, Langella S, Russolillo N, Capussotti L. Locally advanced gallbladder cancer: which patients benefit from resection? Eur J Surg Oncol. 2014;40:1008-1015. [PMID: 24246608 DOI: 10.1016/j.ejso.2013.10.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
4 Chang Y, Li Q, Wu Q, Chi L, Bi X, Zeng Q, Huo H. Impact of surgical strategies on the survival of gallbladder cancer patients: analysis of 715 cases. World J Surg Oncol 2020;18:142. [PMID: 32590998 DOI: 10.1186/s12957-020-01915-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Beal EW, Mehta R, Tsilimigras DI, Hyer JM, Paredes AZ, Merath K, Dillhoff ME, Cloyd JM, Ejaz A, Pawlik TM. Travel to a high volume hospital to undergo resection of gallbladder cancer: does it impact quality of care and long-term outcomes? HPB 2020;22:41-9. [DOI: 10.1016/j.hpb.2019.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
6 Gil L, Lendoire J, Duek F, Quarin C, Garay V, Raffin G, Rivaldi M, Imventarza O. [Radical surgery for incidental gallbladder cancer: the value of a deferred pathological finding of residual disease]. Cir Esp 2014;92:168-74. [PMID: 24439474 DOI: 10.1016/j.ciresp.2013.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
7 Amini N, Ejaz A, Spolverato G, Maithel SK, Kim Y, Pawlik TM. Management of Lymph Nodes During Resection of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Systematic Review. J Gastrointest Surg 2014;18:2136-48. [DOI: 10.1007/s11605-014-2667-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
8 Cho SY, Kim SH, Park SJ, Han SS, Kim YK, Lee KW, Lee WJ, Woo SM, Kim TH. Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol. 2010;102:87-93. [PMID: 20578085 DOI: 10.1002/jso.21544] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
9 Spolverato G, Bagante F, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Winslow E, Cho C, Martin RC, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM. Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer. World J Surg 2017;41:224-31. [PMID: 27549595 DOI: 10.1007/s00268-016-3691-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
10 Hu J, Tang J, Lin C, Chu Y, Liu N. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis. J Investig Med 2018;66:52-61. [DOI: 10.1136/jim-2017-000472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
11 Corwin MT, Khera SS, Loehfelm TW, Yang NT, Fananapazir G. Incidentally Detected Focal Fundal Gallbladder Wall Thickening at Contrast-Enhanced Computed Tomography: Prevalence and Computed Tomography Features of Malignancy. J Comput Assist Tomogr. 2019;43:149-154. [PMID: 30371615 DOI: 10.1097/rct.0000000000000802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
12 Chong JU, Lee WJ. Oncologic Outcomes of Extended Lymphadenectomy without Liver Resection for T1/T2 Gallbladder Cancer. Yonsei Med J 2019;60:1138-45. [PMID: 31769244 DOI: 10.3349/ymj.2019.60.12.1138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhu J, Zhang XR, Yang H. Effects of combined epidural and general anesthesia on intraoperative hemodynamic responses, postoperative cellular immunity, and prognosis in patients with gallbladder cancer: A randomized controlled trial. Medicine (Baltimore) 2017;96:e6137. [PMID: 28272202 DOI: 10.1097/MD.0000000000006137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lian S, Shao Y, Liu H, He J, Lu W, Zhang Y, Jiang Y, Zhu J. PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer. Oncotarget 2015;6:29076-86. [PMID: 26318166 DOI: 10.18632/oncotarget.4931] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
15 Geng Z, Cai Z, Zhang Z, Tang Z, Xue F, Chen C, Zhang D, Li Q, Zhang R, Li W, Wang L, Si S. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma. WJG 2019;25:5655-66. [DOI: 10.3748/wjg.v25.i37.5655] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
16 Chen C, Wang L, Zhang R, Li Q, Zhao YL, Zhang GJ, Li WZ, Geng ZM. Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer. Chronic Dis Transl Med 2019;5:188-96. [PMID: 31891130 DOI: 10.1016/j.cdtm.2019.08.004] [Reference Citation Analysis]
17 Singh SK, Talwar R, Kannan N, Tyagi AK, Jaiswal P, Kumar A. Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre. J Gastrointest Cancer 2018;49:268-74. [PMID: 28367607 DOI: 10.1007/s12029-017-9940-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
18 Oguro S, Ino Y, Shimada K, Hatanaka Y, Matsuno Y, Esaki M, Nara S, Kishi Y, Kosuge T, Hiraoka N. Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer. Cancer Sci 2015;106:1750-60. [PMID: 26395180 DOI: 10.1111/cas.12825] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
19 Wang Z, Li Y, Jiang W, Yan J, Dai J, Jiao B, Yin Z, Zhang Y. Simple Cholecystectomy Is Adequate for Patients With T1b Gallbladder Adenocarcinoma < 1 cm in Diameter. Front Oncol 2019;9:409. [PMID: 31192121 DOI: 10.3389/fonc.2019.00409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
20 Creasy JM, Goldman DA, Gonen M, Dudeja V, Askan G, Basturk O, Balachandran VP, Allen PJ, DeMatteo RP, D'Angelica MI, Jarnagin WR, Peter Kingham T. Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies. J Gastrointest Surg 2017;21:1254-61. [PMID: 28484891 DOI: 10.1007/s11605-017-3436-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
21 Keane FK, Zhu AX, Hong TS. Radiotherapy for Biliary Tract Cancers. Seminars in Radiation Oncology 2018;28:342-50. [DOI: 10.1016/j.semradonc.2018.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
22 Cavallaro A, Piccolo G, Panebianco V, Lo Menzo E, Berretta M, Zanghì A, Di Vita M, Cappellani A. Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding. World J Gastroenterol. 2012;18:4019-4027. [PMID: 22912553 DOI: 10.3748/wjg.v18.i30.4019] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
23 Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades. J Cell Mol Med 2020;24:760-71. [PMID: 31762191 DOI: 10.1111/jcmm.14785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
24 Pandit N, Yadav TN, Awale L, Mahat B, Adhikary S. Management and Outcome of Gallbladder Carcinoma with Obstructive Jaundice: a Retrospective Study from Eastern Nepal. SN Compr Clin Med 2020;2:942-7. [DOI: 10.1007/s42399-020-00317-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 de Aretxabala X, Oppliger F, Solano N, Rencoret G, Vivanco M, Carvajal D, Hepp J, Roa I. Laparoscopic management of incidental gallbladder cancer. Surg Endosc 2018;32:4251-5. [DOI: 10.1007/s00464-018-6173-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
26 Perlmutter BC, Naples R, Hitawala A, McMichael J, Chadalavada P, Padbidri V, Haddad A, Simon R, Walsh RM, Augustin T. Factors that Minimize Curative Resection for Gallbladder Adenocarcinoma: an Analysis of Clinical Decision-Making and Survival. J Gastrointest Surg 2021. [PMID: 33565014 DOI: 10.1007/s11605-021-04942-1] [Reference Citation Analysis]
27 Du JH, Lu J. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient. J Clin Lab Anal 2019;33:e22684. [PMID: 30461064 DOI: 10.1002/jcla.22684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
28 Wu SC, Chen WT, Muo CH, Sung FC. Appendicitis as an early manifestation of subsequent malignancy: an asian population study. PLoS One 2015;10:e0122725. [PMID: 25915658 DOI: 10.1371/journal.pone.0122725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Qadan M, Kingham TP. Technical Aspects of Gallbladder Cancer Surgery. Surg Clin North Am 2016;96:229-45. [PMID: 27017862 DOI: 10.1016/j.suc.2015.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
30 Goussous N, Maqsood H, Patel K, Ferdosi H, Muhammad N, Sill AM, Kowdley GC, Cunningham SC. Clues to predict incidental gallbladder cancer. Hepatobiliary & Pancreatic Diseases International 2018;17:149-54. [DOI: 10.1016/j.hbpd.2018.02.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
31 Albazaz R, Patel CN, Chowdhury FU, Scarsbrook AF. Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours. Insights Imaging. 2013;4:691-700. [PMID: 23884572 DOI: 10.1007/s13244-013-0268-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
32 Wang XA, Xiang SS, Li HF, Wu XS, Li ML, Shu YJ, Zhang F, Cao Y, Ye YY, Bao RF. Cordycepin induces S phase arrest and apoptosis in human gallbladder cancer cells. Molecules. 2014;19:11350-11365. [PMID: 25090123 DOI: 10.3390/molecules190811350] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
33 Maruyama S, Kawaida H, Hosomura N, Amemiya H, Saito R, Shimizu H, Furuya S, Akaike H, Kawaguchi Y, Sudo M, Inoue S, Kono H, Ichikawa D. Indications for extrahepatic bile duct resection due to perineural invasion in patients with gallbladder cancer. World J Surg Oncol 2019;17:200. [PMID: 31785615 DOI: 10.1186/s12957-019-1735-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Niu GC, Shen CM, Cui W, Li Q. Surgical treatment of advanced gallbladder cancer. Am J Clin Oncol. 2015;38:5-10. [PMID: 25616200 DOI: 10.1097/coc.0b013e318287bb48] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
35 Feng X, Cao JS, Chen MY, Zhang B, Juengpanich S, Hu JH, Topatana W, Li SJ, Shen JL, Xiao GY, Cai XJ, Yu H. Laparoscopic surgery for early gallbladder carcinoma: A systematic review and meta-analysis. World J Clin Cases 2020;8:1074-86. [PMID: 32258078 DOI: 10.12998/wjcc.v8.i6.1074] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Hickman L, Contreras C. Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am. 2019;99:337-355. [PMID: 30846038 DOI: 10.1016/j.suc.2018.12.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
37 Hyder O, Dodson RM, Sachs T, Weiss M, Mayo SC, Choti MA, Wolfgang CL, Herman JM, Pawlik TM. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis. Surgery. 2014;155:85-93. [PMID: 23876364 DOI: 10.1016/j.surg.2013.06.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
38 Molnár FT, Horváth OP, Farkas L, Gerlinger I, Pajor L, Kelemen D, Kalmár Nagy K, Tizedes G, Pavlovics G, Bódis J, Gocze P, Szekeres G. [From the surgical field to the microscope. A new tool to identify the lymph node specimens in oncologic surgery]. Magy Seb 2011;64:6-11. [PMID: 21330257 DOI: 10.1556/MaSeb.64.2011.1.2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Kim YJ, Kim K. Conditional survival in patients with gallbladder cancer. Chin J Cancer 2017;36:85. [PMID: 29084608 DOI: 10.1186/s40880-017-0252-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Cavallaro A, Piccolo G, Di Vita M, Zanghì A, Cardì F, Di Mattia P, Barbera G, Borzì L, Panebianco V, Di Carlo I, Cavallaro M, Cappellani A. Managing the incidentally detected gallbladder cancer: algorithms and controversies. Int J Surg 2014;12 Suppl 2:S108-19. [PMID: 25182380 DOI: 10.1016/j.ijsu.2014.08.367] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
41 Goel M, Khobragade K, Patkar S, Kanetkar A, Kurunkar S. Robotic surgery for gallbladder cancer: Operative technique and early outcomes.J Surg Oncol. 2019;119:958-963. [PMID: 30802316 DOI: 10.1002/jso.25422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
42 Xiao Z, Shi Z, Hu L, Gao Y, Zhao J, Liu Y, Xu Q, Huang D. A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. Ann Transl Med. 2019;7:738. [PMID: 32042754 DOI: 10.21037/atm.2019.11.112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
43 Hoehn RS, Wima K, Ertel AE, Meier A, Ahmad SA, Shah SA, Abbott DE. Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data Base. J Gastrointest Surg. 2015;19:1794-1801. [PMID: 26293376 DOI: 10.1007/s11605-015-2922-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
44 Goetze TO, Paolucci V. Prognosis of incidental gallbladder carcinoma is not influenced by the primary access technique: analysis of 837 incidental gallbladder carcinomas in the German Registry. Surg Endosc 2013;27:2821-8. [PMID: 23404149 DOI: 10.1007/s00464-013-2819-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
45 Panebianco A, Volpi A, Lozito C, Prestera A, Ialongo P, Palasciano N. Incidental gallbladder carcinoma: our experience. G Chir 2013;34:167-9. [PMID: 23837956 DOI: 10.11138/gchir/2013.34.5.167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
46 Butt Z, Parikh ND, Beaumont JL, Rosenbloom SK, Syrjala KL, Abernethy AP, Benson AB 3rd, Cella D. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI). Cancer 2012;118:5997-6004. [PMID: 22605658 DOI: 10.1002/cncr.27588] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
47 Yu LH, Yuan B, Fu XH, Yu WL, Liu J, Zhang YJ. Does Anatomic Resection Get More Benefits than Wedge Hepatectomy on the Prognosis for pT3 Unsuspected Gallbladder Cancer?J Laparoendosc Adv Surg Tech A. 2019;29:1414-1418. [PMID: 31403381 DOI: 10.1089/lap.2018.0690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Zhan M, Yang RM, Wang H, He M, Chen W, Xu SW, Yang LH, Liu Q, Long MM, Wang J. Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients. Cancer Commun (Lond) 2018;38:48. [PMID: 30016995 DOI: 10.1186/s40880-018-0318-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
49 Gani F, Buettner S, Margonis GA, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM. Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer. J Surg Oncol 2016;114:176-80. [PMID: 27198742 DOI: 10.1002/jso.24283] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
50 Dixit R, Raza M, Kumar M, Basu S, Shukla VK. Expression Analysis of Survivin and XIAP in Gallbladder Cancer: a Case-control Study in Indo-Gangetic Plain. J Gastrointest Canc 2018;49:487-92. [DOI: 10.1007/s12029-017-0008-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Piccolo G, Piozzi GN. Laparoscopic Radical Cholecystectomy for Primary or Incidental Early Gallbladder Cancer: The New Rules Governing the Treatment of Gallbladder Cancer. Gastroenterol Res Pract 2017;2017:8570502. [PMID: 28690639 DOI: 10.1155/2017/8570502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
52 Kasle D, Rahnemai-Azar AA, Bibi S, Gaduputi V, Gilchrist BF, Farkas DT. Carcinoma in situ in a 7 mm gallbladder polyp: Time to change current practice? World J Gastrointest Endosc 2015;7:912-5. [PMID: 26240692 DOI: 10.4253/wjge.v7.i9.912] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
53 Lian S, Shao Y, Liu H, He J, Lu W, Zhang Y, Jiang Y, Zhu J. PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer. Oncotarget. 2015;6:29076-29086. [PMID: 26318166 DOI: 10.18632/oncotarget.49314931] [Reference Citation Analysis]
54 de Savornin Lohman E, de Bitter T, Verhoeven R, van der Geest L, Hagendoorn J, Haj Mohammad N, Daams F, Klümpen HJ, van Gulik T, Erdmann J, de Boer M, Hoogwater F, Koerkamp BG, Braat A, Verheij J, Nagtegaal I, van Laarhoven C, van den Boezem P, van der Post R, de Reuver P. Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort. Cancers (Basel) 2020;12:E918. [PMID: 32283627 DOI: 10.3390/cancers12040918] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
55 He XD, Li JJ, Liu W, Qu Q, Hong T, Xu XQ, Li BL, Wang Y, Zhao HT. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer. World J Gastroenterol 2015;21:4620-6. [PMID: 25914471 DOI: 10.3748/wjg.v21.i15.4620] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
56 John S, Moyana T, Shabana W, Walsh C, McInnes MDF. Gallbladder Cancer: Imaging Appearance and Pitfalls in Diagnosis [Formula: see text]. Can Assoc Radiol J 2020;71:448-58. [PMID: 32412302 DOI: 10.1177/0846537120923273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Kasumova GG, Tabatabaie O, Najarian RM, Callery MP, Ng SC, Bullock AJ, Fisher RA, Tseng JF. Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy. Ann Surg. 2017;266:625-631. [PMID: 28692469 DOI: 10.1097/sla.0000000000002385] [Cited by in Crossref: 55] [Cited by in F6Publishing: 19] [Article Influence: 13.8] [Reference Citation Analysis]
58 Lee H, Choi DW, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Jang KT. Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location. Ann Surg Oncol. 2015;22:2779-2786. [PMID: 25519930 DOI: 10.1245/s10434-014-4300-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
59 Lendoire JC, Gil L, Duek F, Quarin C, Garay V, Raffin G, Rivaldi M, Alejandra O, Imventarza O. Relevance of residual disease after liver resection for incidental gallbladder cancer. HPB (Oxford). 2012;14:548-553. [PMID: 22762403 DOI: 10.1111/j.1477-2574.2012.00498.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
60 Butte JM, Kingham TP, Gönen M, D'Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR. Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg 2014;219:416-29. [PMID: 25087941 DOI: 10.1016/j.jamcollsurg.2014.01.069] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
61 Jin LX, Pitt SC, Hall BL, Pitt HA. Aggressive surgical management of gallbladder cancer: at what cost? Surgery. 2013;154:266-273. [PMID: 23830031 DOI: 10.1016/j.surg.2013.04.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
62 Vinuela E, Vega EA, Yamashita S, Sanhueza M, Mege R, Cavada G, Aloia TA, Chun YS, Lee JE, Vauthey J, Conrad C. Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries. Ann Surg Oncol 2017;24:2334-43. [DOI: 10.1245/s10434-017-5859-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
63 Tong C, Wang Y, Li J, Cen W, Zhang W, Zhu Z, Yu J, Lu B. Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway. Sci Rep 2021;11:4391. [PMID: 33623100 DOI: 10.1038/s41598-021-83924-4] [Reference Citation Analysis]
64 Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) 2016;18:872-8. [PMID: 27527802 DOI: 10.1016/j.hpb.2016.05.016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 6.6] [Reference Citation Analysis]
65 Li Y, Zhang J, Ma H. Chronic inflammation and gallbladder cancer. Cancer Lett. 2014;345:242-248. [PMID: 23981574 DOI: 10.1016/j.canlet.2013.08.034] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
66 Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Kawasaki Y, Mori S, Arigami T, Kijima Y, Shinchi H, Natsugoe S. Indication of extrahepatic bile duct resection for gallbladder cancer. Langenbecks Arch Surg 2018;403:45-51. [PMID: 28875312 DOI: 10.1007/s00423-017-1620-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
67 Bo X, Wang J, Fu Q, Wang Y, Liu H, Xu J. Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma. Oncotarget 2017;8:108548-55. [PMID: 29312550 DOI: 10.18632/oncotarget.19625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
68 Swank HA, Mulder IM, Hop WC, van de Vijver MJ, Lange JF, Bemelman WA. Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: a systematic review. Surg Endosc 2013;27:4439-48. [PMID: 23877761 DOI: 10.1007/s00464-013-3084-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
69 Wernberg JA, Lucarelli DD. Gallbladder cancer. Surg Clin North Am. 2014;94:343-360. [PMID: 24679425 DOI: 10.1016/j.suc.2014.01.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 49] [Article Influence: 10.1] [Reference Citation Analysis]
70 Lim JH, Chong JU, Kim SH, Park SW, Choi JS, Lee WJ, Kim KS. Role of common bile duct resection in T2 and T3 gallbladder cancer patients. Ann Hepatobiliary Pancreat Surg. 2018;22:42-51. [PMID: 29536055 DOI: 10.14701/ahbps.2018.22.1.42] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
71 Shao Y, Zhou Y, Hou Y, He J, Hu L, Zhang Y, Jiang Y, Lu W, Liu H. Prognostic implications of SLIT and ROBO1 expression in gallbladder cancer. Cell Biochem Biophys 2014;70:747-58. [PMID: 24777813 DOI: 10.1007/s12013-014-9976-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
72 Kim SH, Chong JU, Lim JH, Choi GH, Kang CM, Choi JS, Lee WJ, Kim KS. Optimal assessment of lymph node status in gallbladder cancer. Eur J Surg Oncol. 2016;42:205-210. [PMID: 26614023 DOI: 10.1016/j.ejso.2015.10.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
73 Chen JB, Pan ZB, Du DM, Qian W, Ma YY, Mu F, Xu KC. Hydrogen gas therapy induced shrinkage of metastatic gallbladder cancer: A case report. World J Clin Cases 2019;7:2065-74. [PMID: 31423439 DOI: 10.12998/wjcc.v7.i15.2065] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
74 Baig M, Guarino M, Petrelli N. Report on demographics of gall bladder cancer in Delaware and retrospective review of treatment strategies for gallbladder cancer in a large community cancer center. Surgical Oncology 2016;25:86-91. [DOI: 10.1016/j.suronc.2016.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
75 Butte JM, Gönen M, Allen PJ, D'Angelica MI, Kingham TP, Fong Y, Dematteo RP, Blumgart L, Jarnagin WR. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford) 2011;13:463-72. [PMID: 21689230 DOI: 10.1111/j.1477-2574.2011.00325.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
76 Butte JM, Matsuo K, Gönen M, D'angelica MI, Waugh E, Allen PJ, Fong Y, Dematteo RP, Blumgart L, Endo I, De La Fuente H, Jarnagin WR. Gallbladder Cancer: Differences in Presentation, Surgical Treatment, and Survival in Patients Treated at Centers in Three Countries. Journal of the American College of Surgeons 2011;212:50-61. [DOI: 10.1016/j.jamcollsurg.2010.09.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
77 Amini N, Spolverato G, Kim Y, Gupta R, Margonis GA, Ejaz A, Pawlik TM. Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems. J Surg Oncol 2015;111:299-305. [PMID: 25312786 DOI: 10.1002/jso.23813] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
78 Williams TM, Majithia L, Wang SJ, Thomas CR. Defining the Role of Adjuvant Therapy: Cholangiocarcinoma and Gall Bladder Cancer. Seminars in Radiation Oncology 2014;24:94-104. [DOI: 10.1016/j.semradonc.2014.01.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
79 Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22:249-273. [PMID: 25787274 DOI: 10.1002/jhbp.233] [Cited by in Crossref: 119] [Cited by in F6Publishing: 89] [Article Influence: 19.8] [Reference Citation Analysis]
80 Ausania F, Tsirlis T, White SA, French JJ, Jaques BC, Charnley RM, Manas DM. Incidental pT2-T3 gallbladder cancer after a cholecystectomy: outcome of staging at 3 months prior to a radical resection. HPB (Oxford) 2013;15:633-7. [PMID: 23458168 DOI: 10.1111/hpb.12032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
81 Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis 2020;11:871. [PMID: 33067424 DOI: 10.1038/s41419-020-03080-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
82 de Savornin Lohman EA, Kuipers H, van Dooren M, Verhoeven RH, Erdmann JI, Groot Koerkamp B, Braat AE, Hagendoorn J, Daams F, van Dam R, van Gulik TM, de Boer MT, de Reuver PR. Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort study. HPB 2020;22:1686-94. [DOI: 10.1016/j.hpb.2020.03.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Andrén-Sandberg A. Diagnosis and management of gallbladder cancer. N Am J Med Sci. 2012;4:293-299. [PMID: 22866265 DOI: 10.4103/1947-2714.98586] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
84 Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, Herman J, Schulick RD, Choti MA, Pawlik TM. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010;14:1578-1591. [PMID: 20824371 DOI: 10.1007/s11605-010-1335-3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 60] [Article Influence: 7.2] [Reference Citation Analysis]
85 Kim DH, Kim SH, Choi GH, Kang CM, Kim KS, Choi JS, Lee WJ. Role of Cholecystectomy and Lymph Node Dissection in Patients with T2 Gallbladder Cancer. World J Surg 2013;37:2635-40. [DOI: 10.1007/s00268-013-2187-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
86 Birnbaum DJ, Viganò L, Russolillo N, Langella S, Ferrero A, Capussotti L. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio. Ann Surg Oncol 2015;22:811-8. [PMID: 25201500 DOI: 10.1245/s10434-014-4044-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
87 Sheikh MR, Osman H, Cheek S, Hunter S, Jeyarajah DR. T2 Gallbladder Cancer-Aggressive Therapy Is Warranted. Am Surg 2016;82:518-21. [PMID: 27305883 DOI: 10.1177/000313481608200612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
88 Butte JM, Waugh E, Meneses M, Parada H, De La Fuente HA. Incidental gallbladder cancer: analysis of surgical findings and survival. J Surg Oncol. 2010;102:620-625. [PMID: 20721958 DOI: 10.1002/jso.21681] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
89 Marsh Rde W, Alonzo M, Bajaj S, Baker M, Elton E, Farrell TA, Gore RM, Hall C, Nowak J, Roy H. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. J Surg Oncol. 2012;106:339-345. [PMID: 22488601 DOI: 10.1002/jso.23027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]